🚨 Profit Panel is live at 9:30 a.m. ET🚨
[tap to join us for Profit Panel]
I don’t usually wade into the AI hype, but something’s been sitting with me for a while now, and I figure it’s worth putting out there.
We keep hearing about how powerful artificial intelligence is going to be — how it’ll change everything, disrupt every industry and remake the world. Fine.
But here’s what I want to know: If AI is genuinely as powerful as everyone claims, why aren’t we feeding it all the medical school criteria, biochemistry knowledge and pharmaceutical data — and tasking it with solving one of the most frustrating problems in modern medicine?
I’m talking about drug side effects.
The Problem Every Drug Commercial Reveals
Listen to any drug commercial on the radio or TV, and every single one of them has nasty, gnarly side effects. Half of them could kill you if you’re allergic, and here’s the kicker: How do you even know if you’re allergic until you take the drug?
That’s not a small problem. It’s not even just a safety issue.
The current model often requires you to take other drugs just to offset what the first drug is doing — and then maybe another to manage what that second one causes.
It’s a pharmaceutical cascade that feels more like patch management than actual healing.
What Meaningful Progress Could Look Like
So here’s my thought: What if AI could help create pharmaceuticals that target one specific condition without triggering a pile of side effects?
What if it could analyze genetic differences and help doctors build individualized treatment plans instead of prescribing the same standard course to everyone?
The possibilities go beyond better drugs. AI could potentially support gene-editing research, personalized therapies and the search for treatments for diseases such as cancer and type-1 diabetes.
There appears to be real progress in applying AI to medicine, which gives me some hope, even if the work remains difficult and the results are still developing.
That is also where responsibility comes in. AI companies make enormous claims about what their systems can do, but those claims should eventually produce measurable human benefits. If this technology is as capable as advertised, show us meaningful progress.
Help cure a disease. Help doctors choose safer treatments. Help patients avoid taking one medication just to manage the damage caused by another.
If AI could solve even part of this pharmaceutical problem, that would be fantastic — and honestly, it would be well worth the investment and development we’re pouring into the technology. It might even improve the industry’s reputation, though that should be a byproduct rather than the goal.
I don’t know whether AI can accomplish all of this. I’m not pretending to have the answer. But if we’re going to talk about where artificial intelligence could deliver genuine value — not just hype or efficiency gains but real human benefit — this feels like the place to start.
I’m not pitching this as an investment theme or telling you to chase biotech stocks. I’m just saying: If this is one thing AI could help fix, it’d matter more than most of what we hear about.
Geof Smith
Geof Smith TradingÂ
Follow along and join the conversation for real-time analysis, trade ideas, market insights and more!
- Telegram: https://t.me/+lm8_Nq3Su104NmFh
- YouTube: https://www.youtube.com/@FinancialWars
Important Note: No one from the ProsperityPub team or Geof Smith Trading will ever contact you directly on Telegram.
*This is for informational and educational purposes only. There is inherent risk in trading, so trade at your own risk.Â
P.S. Are You Ready for Today’s Urgent Roundtable at 3:30PM ET?
Are you ready for today’s roundtable at 3:30 p.m. ET?
The Fed raised rates for the first time in three years!
Andfrom what we’ve seen in the news, more raises could come.
At the same time, Brent Crude is hovering around $100, and Treasury yields are at their highest since July 2007.
This creates high uncertainty for traders as we head into the last stretch of 2026.
That’s why today’s urgent Roundtable at 3:30 p.m. ET with Emily, Kane, Nate and me couldn’t have come at a better time.
We’ll share where we see the market going with all this back-and-forth in question…
And the no.1 game plan to play what’s going on right now.
Signals from this play have delivered 31 winners out of 34 this year alone, through all the chaos.
No reckless trading guarantees here…
But Tap Here to Save Your Roundtable Seat
Disclaimer: We develop tools and strategies to the best of our ability, but we can’t guarantee the future. Trading always carries a risk of loss. Past performance is not indicative of future results, from 8/6/2024 to 9/8/2026. The win rate is 88.7%, with an average return of 5.80% over a 3-day hold time.
